Myeloma bone marrow plasma cells: Evidence for their capacity as antigen-presenting cells

Keyphrases

• Myeloma 100%
• Antigen-presenting Cells 100%
• CD38 100%
• Bone Marrow Plasma Cells 100%
• Plasma Cells 71%
• Interferon-α (IFN-α) 28%
• Costimulatory Molecules 28%
• Major Histocompatability Complex 28%
• T Cell Activation 14%
• Tetanus Toxoid 14%
• Tumor Necrosis Factor-α 14%
• T Cell Proliferation 14%
• Cell Surface Markers 14%
• Allogeneic T Cells 14%
• Bone Marrow Cells 14%
• Multiple Myeloma 14%
• Antigen Presentation 14%
• HLA-DR 14%
• Adhesion Molecules 14%
• CD86 14%
• Bone Marrow Mononuclear Cells 14%
• Cell Count 14%
• Surface Antigen 14%
• Autologous T Cell 14%
• Capacity to Act 14%
• Antigen Processing 14%
• Professional Antigen-presenting Cells 14%
• CD40 14%
• Soluble Antigen 14%
• Chloroquine 14%
• Multiple Myeloma Patients 14%
• Purified Protein Derivative 14%
• Bone Marrow Aspirate 14%
• CD80 14%
• Cell Secretion 14%
• Complex Molecules 14%
• HLA-DR Antigens 14%
• HLA-DQ 14%
• HLA-ABC 14%

Immunology and Microbiology

• Immunoglobulin Producing Cell 100%
• Antigen-Presenting Cell 100%
• CD38 100%
• T Cell 42%
• Multiple Myeloma 42%
• Interferon 28%
• Antigen Presentation 28%
• Tetanus Vaccine 14%
• Tumor Necrosis Factor 14%
• T Cell Proliferation 14%
• Cell Surface Marker 14%
• Bone Marrow Cell 14%
• Blood Plasma 14%
• Mononuclear Cell 14%
• HLA-DR 14%
• CD86 14%
• Cell Count 14%
• Cell Stimulation 14%
• CD80 14%
• Tuberculin 14%
• Chloroquine 14%
• HLA DR Antigen 14%
• Cellular Secretion 14%
• HLA-DQ 14%